- Daley MJ, Murthy MS, and Peterson EJ. Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem. Therapeutic Advances in Drug Safety, 2015; 6(2): 57-66.
- Jaff MR, McMurtry MS, Archer SL et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation, 2011; 123 (16): 1788-1830.
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Respir J 2019.
- Tong CR and Zhang ZH. Evaluation factors of Pulmonary Embolism Severity and Prognosis. Clinical and Applied Thrombosis/Hemostasis, 2015; 21 (3): 273-284.
- Yamamoto T. Management of patients with high-risk pulmonary embolism: a narrative review. Journal of Intensive Care, 2018.